Navigation Links
Preliminary Lineup Set for 4th Annual Stem Cell Summit

Stem Cell Company Executives, Scientists and Investors Will Gather Feb. 17

in New York City to Discuss Commercialization of Stem Cell Products

PHILADELPHIA, Aug. 12 /PRNewswire/ -- RRY Publications today announced the preliminary lineup of presenters for the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products. The Stem Cell Summit is an intensive one-day event that allows attendees to explore the therapeutic applications of stem cells, the successful path to stem cell product commercialization, and the latest investment opportunities within this marketplace.

The 4th Annual Stem Cell Summit features 35 corporate presenters, keynote speaker Dr. Arnold Caplan, Ph.D., and a scientific panel discussion. It will take place on February 17, 2009, at Bridgewaters in the heart of New York City's historic South Street Seaport.

Confirmed presenting stem cell companies include:

3DM, Inc. Incell Corporation, LLC

Aastrom Biosciences, Inc. MaxCyte, Inc.

Aldagen, Inc. Moraga Biotechnology Corporation

AllCells, LLC Neuronyx, Inc.

Arteriocyte, Inc. Novocell, Inc.

BioE Corp. NuVasive, Inc.

California Stem Cell, Inc. Osiris Therapeutics, Inc.

Cellerix, S.A. Progenitor Cell Therapy, Inc.

Cognate BioServices, Inc. Stemagen

Cytori Therapeutics, Inc. Stemina, Inc.

Gamida Cell Ltd. TiGenix NV

Geron Corp. Tissue Genesis, Inc.

Harvest Technologies Corp. Vet-Stem, Inc.

Histogen, Inc.

In addition to the company and product overviews, Robin R. Young, CFA, the leading medical technologies analyst in the United States with over 25 years' experience in the cardiovascular, orthopedic and biomaterials industries and the award-winning president and organizer of the annual Stem Cell Summit, will deliver his updated 10-year market forecast for the industry.

"2008 has already been a record-breaking year for stem cell technologies with two of the largest purchase contracts ever recorded - one for more than $200 million from the U.S. government and another for $85 million to purchase a single stem cell product line," said Robin Young. "There is little doubt that 2009 will be the year that stem cell companies and technologies cross the $100 million in annual revenues line and become a billion-dollar valuation industry."

4th Annual Stem Cell Summit Facts at a Glance

What: 2009's Premier Gathering of Stem Cell Company Executives,

Scientists and Investors

When: February 17, 2009

Where: Bridgewaters

11 Fulton Street

New York City

Who: The Stem Cell Summit is organized by Robin R. Young, CFA and RRY

Publications, LLC.

Admission: $950 early bird registration by November 30, 2008

$1,200 advance registration (December 1, 2008 - January 31,


$1,500 (February 1 - 17, 2009)

Information: For more information on presentation or sponsorship

opportunities, call Lisa Carpenter at 877-817-6450 or send an

email to . Additional information, including

attendee registration details, is available at

Contacts: Lisa Carpenter

RRY Publications, LLC


SOURCE RRY Publications
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sunrise Updates Date and Time of Conference Call to Discuss 2007 Financial Results and Second-Quarter 2008 Preliminary Selected Financial and Operating Data
2. Misys Announces Preliminary Results for the Year Ended 31 May 2008
3. Longs Reports Preliminary June Retail Drug Store Sales
4. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
5. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
6. Longs Reports Preliminary May Retail Drug Store Sales
7. AVMA Declares Preliminary Victory on Farm Bill Provisions
8. NBTY Announces Preliminary Unaudited Net Sales Results for April 2008
9. ENDO 08 preliminary news conference and webcast schedule
10. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
11. WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... GKhair & Tibolli ... the San Juan Beauty Show held on November 8th and 9th at the Puerto ... media personalities, hair artists, renowned beauticians and top of the line fashion journalists. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that ... Program with competencies in the Application Development, demonstrating a “best-in-class” ability and ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... product dealer. Joining more than 30 HealthPostures’ dealers located throughout the United States, ... increase the number of corporate, industrial, manufacturing and government workers and organizational leaders ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... patented products, announces the Unstoppable Swappables, a household invention that provides an economical ... $2 billion a year and is growing at 2.6%," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology: